Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

New Cyanine Dyes Reduce Time and Cost of Oligo Labelling

Published: Monday, March 25, 2013
Last Updated: Sunday, March 24, 2013
Bookmark and Share
Link Technologies’ solid-supported Cyanine 540 and 650 dyes increase workflow efficiency.

Link Technologies Ltd has launched a range of high quality cyanine dye products to support the continued increase in demand for fluorescent labelling in biological imaging and molecular diagnostics.

As well as introducing a new range of 3’-CPG solid supports modified with Cyanine 540 and Cyanine 650, Link Technologies now also manufactures and supplies the commonly used phosphoramidites, so researchers can now source an extended range of cyanine reagents produced to Link Technologies’ exacting standards.

Until now, 3’-cyanine modification of an oligonucleotide could only be done post-synthetically, normally to an amino-modified oligo, or by the use of a cyanine phosphoramidite onto a universal or modified support that will not interfere with the intended use of the oligo.

With Link Technologies’ innovative 3’-modified 1000Å CPG supports, customers can add cyanine dyes directly to their oligos of interest without any additional modification step.

Link Technologies’ cyanine dye supports therefore save time by reducing the number of experimental steps and avoid the unnecessary cost of amino-modified oligos or the inconvenience of combining cyanine phosphoramidites and universal supports.

Used as fluorescent markers in oligonucleotide synthesis, dyes are central to numerous detection techniques, such as probes for monitoring real-time PCR, fluorescence in situ hybridization, SERRS-based DNA detection assays and FRET studies in general (e.g. DNA-protein interaction studies).

3’-Labelling is particularly useful in the latter where the FRET partner is incorporated either at the 5’-end or within the oligonucleotide sequence.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,100+ scientific posters on ePosters
  • More Than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

LINK Strengthens Presence in Switzerland
Link Technologies appoints Swiss company as first partner in Europe.
Tuesday, September 08, 2015
LINK Strengthens Presence in Switzerland with Distribution Agreement
Link Technologies appoints Swiss company Chemie Brunschwig AG as first partner in Europe.
Friday, September 04, 2015
LINK Strengthens Presence in Japan with New Distribution Agreements
Link Technologies appoints Cosmo Bio and Shigematsu to work alongside Gene Design.
Tuesday, June 30, 2015
LINK Strengthens Board with Appointment of Marc Lemaître
Lemaître to join Link Technologies Ltd. as non-executive Director.
Wednesday, February 25, 2015
New SAB Supports LINK’s Growing Range of Innovative Reagents
LINK creates SAB with Brian Sproat and Thomas Rupp as first two appointments.
Friday, January 16, 2015
LINK Appoints New CEO
LINK has appointed Dr David Ricketts as its new Chief Executive Officer.
Tuesday, September 30, 2014
Shining the Light on Oligonucleotide Labelling
Link Technologies’ new Product Guide is the ‘go-to’ resource for oligo chemistry.
Tuesday, July 23, 2013
Link Technologies Announces Expansion into the Far East with New Distributor
Zirench Technology signed as local distributor for the Chinese market.
Thursday, June 13, 2013
Further Success for Link Technologies in Asia
Japanese company GeneDesign joins growing list of distributors.
Tuesday, February 26, 2013
Link Technologies Announces Partnership with American International Chemical
AIC to distribute Link’s specialist oligonucleotide modifiers in North America.
Wednesday, May 23, 2012
Link Technologies Secures Exclusive License for Ultra Sensitive Diagnostic Probes
Deal marks the start of ongoing collaboration between Link and The University of Manchester.
Tuesday, December 01, 2009
Link Technologies Inks Exclusive License to Agilent Technologies’ TC RNA Monomers
Under the terms of the agreement Link will manufacture and sell the four RNA monomer phosphoramidite reagents for use in research.
Monday, May 18, 2009
PNA Monomers: A Licence to Deal
Link Technologies to manufacture and sell PNA Monomers following deal with PNA Inventor Group.
Friday, June 22, 2007
Scientific News
The Rise of 3D Cell Culture and in vitro Model Systems for Drug Discovery and Toxicology
An overview of the current technology and the challenges and benefits over 2D cell culture models plus some of the latest advances relating to human health research.
Grant Supports Project To Develop Simple Test To Screen For Cervical Cancer
UCLA Engineering announces funding from Bill and Melinda Gates Foundation.
Injecting New Life into Old Antibiotics
A new fully synthetic way to make a class of antibiotics called macrolides from simple building blocks is set to open up a new front in the fight against antimicrobial drug resistance.
Insight into Bacterial Resilience and Antibiotic Targets
Variant of CRISPR technology paired with computerized imaging reveals essential gene networks in bacteria.
Advancing Protein Visualization
Cryo-EM methods can determine structures of small proteins bound to potential drug candidates.
Alzheimer’s Protein Serves as Natural Antibiotic
Alzheimer's-associated amyloid plaques may be part of natural process to trap microbes, findings suggest new therapeutic strategies.
Slime Mold Reveals Clues to Immune Cells’ Directional Abilities
Study from UC San Diego identifies a protein involved in the directional ability of a slime mold.
How Do You Kill A Malaria Parasite?
Drexel University scientists have discovered an unusual mechanism for how two new antimalarial drugs operate: They give the parasite’s skin a boost in cholesterol, making it unable to traverse the narrow labyrinths of the human bloodstream. The drugs also seem to trick the parasite into reproducing prematurely.
Illuminating Hidden Gene Regulators
New super-resolution technique visualizes important role of short-lived enzyme clusters.
Supressing Intenstinal Analphylaxis in Peanut Allergy
Study from National Jewish Health shows that blockade of histamine receptors suppresses intestinal anaphylaxis in peanut allergy.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,100+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!